Supply Chain

Jun 01, 2008
Pharmaceutical Technology Europe
Drug products subjected to degradation because of environmental stresses can be salvaged if proper packaging and protection is provided by sorbents.
May 20, 2008
ePT--the Electronic Newsletter of Pharmaceutical Technology
The European Federation of Pharmaceutical Industries and Associations (EFPIA), the trade association representing European pharmaceutical manufacturers, issued recommendations to the public consultation launched in March by the European Commission's proposed drug anticounterfeiting measures. EFPIA's proposal includes a ban on drug repackaging.
May 09, 2008
PTSM: Pharmaceutical Technology Sourcing and Management
The recent heparin contamination event calls for a new approach to manage a lengthening pharmaceutical supply chain.
Apr 30, 2008
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Researchers from the Georgia Institute of Technology described a fast method to detect counterfeit "Tamiflu," Roche's drug for preventing and treating bird flu.
Apr 02, 2008
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Sophisticated replication techniques have made counterfeiting and fraud a serious threat to the pharmaceutical industry.
Apr 02, 2008
Pharmaceutical Technology
The recent heparin contamination event calls for a new approach to manage a lengthening pharmaceutical supply chain.
Apr 01, 2008
Pharmaceutical Technology Europe
Manufacturing facilities must be inspected by members of regulatory bodies. However… these bodies are woefully inadequate at performing the task.
Apr 01, 2008
Pharmaceutical Technology Europe
Mar 05, 2008
PTSM: Pharmaceutical Technology Sourcing and Management
Draft federal legislation that would require high-risk chemical facilities to use inherently safer technology for reducing their risk may present potential problems for custom and batch manufacturers supplying the pharmaceutical industry.
Jan 01, 2008
Pharmaceutical Technology Europe
How much do you know about parallel trade? Perhaps you may have heard someone mention these words and have then switched off. In a sense, it's hardly surprising given the fact that most media coverage centres on interpretation of complex legal cases. By the time you reach the end of these types of articles, you can't work out what the mentioned companies were arguing about in the first place and on which technical details the case was judged. Yet, time after time, a legal ruling on a parallel trade issue rockets to the front pages of the pharmaceutical press and even, occasionally, the mainstream media.
native1_300x100
lorem ipsum